
Building the bridge
HealthTech Qatar
Connecting health innovation from Europe and elsewhere with the needs, institutions and opportunities of Qatar and the wider GCC.
Explore HealthTech QatarPlaces
A personal route into Qatar, and a view of what its compact, connected health and research ecosystem could make possible.
My relationship with Qatar began in a rather serendipitous way. I was preparing to attend the Global Health Exhibition in Riyadh while participating in a Saudi biotechnology accelerator. I published a LinkedIn post about the trip, praising the Kingdom’s ambition. Someone I had never met saw it and contacted me. He was Professor Said Dermime, a medical researcher at Hamad Medical Corporation and a Clinical Professor at Qatar University. His message was simple: “You should come to Doha instead. This is much better for you.” That was all.
I was buying my flights at the time and thought: why not? I booked the journey through Doha. Qatar was, and remains, a major aviation hub, so the detour was remarkably simple. I met Professor Dermime at Hamad Medical Corporation for what was meant to be a short meeting. It lasted for hours. I have kept returning ever since.
What I found was a small country with an understated but formidable ambition: an exceptionally modern and integrated health system; one of the region’s pioneering population-based genome programmes; universities and research institutions of genuine regional importance, including one of the Arab world’s leading universities; and national strategies that are unusually clear about both ambition and execution. Qatar’s scale is not merely a limitation. It can make coordination between research, clinical care, government and industry more achievable.
The national vision, its current execution strategies and the health reports that show how ambition is being made operational.





The important opportunity is not simply that these assets exist. It is that Qatar is compact enough for its health, research and policy institutions to operate as a connected environment. That makes the country unusually well suited to systematic clinical validation, population-scale evidence generation and the translation of regulated health technologies into practice.
The remaining challenge is to turn scientific and clinical strength into durable industrial capability. I explore that gap in Qatar’s Precision Medicine Leap and in Qatar’s Precision Diagnostics Opportunity: research excellence must be connected to validation pathways, regulation, procurement, venture formation and manufacturing if it is to create lasting clinical and economic value.
I am now putting this thinking into practice through HealthTech Qatar, an independent, entrepreneur-led platform based in Qatar. HTQ connects health innovators in Europe and the wider global health-technology ecosystem with healthcare institutions and strategic priorities in Qatar and the GCC, helping regulated technologies secure the partnerships, validation settings and implementation pathways required for regional deployment.

Building the bridge
Connecting health innovation from Europe and elsewhere with the needs, institutions and opportunities of Qatar and the wider GCC.
Explore HealthTech QatarThree essays tracing Qatar’s precision-medicine assets, its diagnostics opportunity and its role as an innovation platform.
How population genomics, screening infrastructure and strategic investment could underpin a more ambitious innovation economy.
Read the essay →02Why Qatar’s integrated scale creates a distinctive opening for clinical validation, translation and diagnostics industry leadership.
Read the essay →03Reflections on Qatar’s growing role as a meeting point for technology, entrepreneurship and international innovation networks.
Read the essay →The complete archive of writing connected to this place.